First Time Loading...

Haemato AG
XETRA:HAEK

Watchlist Manager
Haemato AG Logo
Haemato AG
XETRA:HAEK
Watchlist
Price: 21.4 EUR -1.83%
Updated: May 1, 2024

Wall Street
Price Targets

HAEK Price Targets Summary
Haemato AG

Wall Street analysts forecast HAEK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HAEK is 34 EUR .

Lowest
Price Target
Not Available
Average
Price Target
34 EUR
59% Upside
Highest
Price Target
Not Available
Haemato AG Competitors:
Price Targets
GALE
Galenica AG
11% Upside
SIG
Sigma Healthcare Ltd
13% Downside
PGC
Paragon Care Ltd
3% Downside
NEU
Neuca SA
1% Upside
1298
Yunnan Energy International Co Ltd
206% Upside

Revenue
Forecast

Revenue Estimate
Haemato AG

For the last 8 years the compound annual growth rate for Haemato AG's revenue is 3%. The projected CAGR for the next 2 years is 10%.

3%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Haemato AG

Operating Income forecast
is not available for
Haemato AG

Net Income
Forecast

Net Income Estimate
Haemato AG

For the last 8 years the compound annual growth rate for Haemato AG's net income is 2%. The projected CAGR for the next 2 years is 11%.

2%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HAEK's stock price target?
Price Target
34 EUR

According to Wall Street analysts, the average 1-year price target for HAEK is 34 EUR .

What is Haemato AG's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Haemato AG's revenue is 3%. The projected CAGR for the next 2 years is 10%.

What is Haemato AG's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Haemato AG's net income is 2%. The projected CAGR for the next 2 years is 11%.